Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
      • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
JIM

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Information for authors
  • About the journal
    • About the journal
    • Editorial board
    • Information for authors
    • FAQs
    • Thank you to our reviewers
    • American Federation for Medical Research
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising

Midwestern Regional Meeting

DOI: 10.1136/jim-2018-000745.1 Published 5 April 2018
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Abstract B02 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B02 Figure 1

    Comparison of M-F 8am–5pm mean sedentary time: baseline to 12-week

  • Abstract B02 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B02 Figure 2

    Comparison of femoral FMD %: baseline to 12-week

  • Abstract B03 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B03 Figure 1

    Cardiac MR with diffuse mass extending into interventricular septum involving both ventricles with encasement of coronary arteries

  • Abstract A31 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A31 Figure 1
  • Abstract A34 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A34 Figure 1
  • Abstract B61 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B61 Figure 1

    Electrocardiagram showing sinus bradycardia with inferior ST-segment elevation in leads II, III, aVF and anterior ST-segment depression in leads V1–4

  • Abstract B61 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B61 Figure 2

    Coronary angiogram show 99% occlusion of dominant mid-left circumflex artery

  • Abstract B61 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B61 Figure 3

    CT abdomen with contrast showing gas in the gallbladder well and lumen representing emphysematous cholecystitis with moderate pneumobilia

  • Abstract B61 Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B61 Figure 4

    CT abdomen with contrast showing 1 to 2 intrahepatic gas containing foci likely representing abscess formation

  • Abstract C29 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C29 Figure 1

    Electrocardiogram with inferolateral ST-segment elevation myocardial infarction

  • Abstract C29 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C29 Figure 2

    Echocardiogram in end systole with left ventricular akinesis. White arrow indicating LV apical thrombus. (LV: left ventricle, RV: right ventricle)

  • Abstract C29 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C29 Figure 3

    Brain MR with area of T2/FLAIR hyperintensity

  • Abstract A16 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A16 Figure 2
  • Abstract A16 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A16 Figure 3
  • Abstract A06 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A06 Figure 1
  • Abstract A06 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A06 Figure 2
  • Abstract A06 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A06 Figure 3
  • Abstract A06 Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A06 Figure 4
  • Abstract A06 Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A06 Figure 5
  • Abstract A62 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A62 Figure 1
  • Abstract B33 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B33 Figure 2
  • Abstract B33 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B33 Figure 3
  • Abstract A37 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A37 Figure 1
  • Abstract A37 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A37 Figure 2
  • Abstract A37 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A37 Figure 3
  • Abstract B62 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B62 Figure 1
  • Abstract C01 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C01 Figure 1
  • Abstract A22 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A22 Figure 2

    Is the gene correlation map of 171 genes enriched in the stroma of pancreatic adenocarcinoma. These genes indude those associated with cytolytic activities, desmoplastic reaction, stromal and immune cells, and genes associated with simulatory or inhibitory signals of antigen presenting cells and Tcells. Each box demonstrates a squared correlation coefficient (R2) of two respective genes

  • Abstract A54 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A54 Figure 1

    Laryndoscopy showing paralysis of left vocal cord

  • Abstract C05 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C05 Figure 1

    Cardiac MRI displaying masses within LV apical septum (1), left lateral wall (2), and inferolateral wall (3). LV: Left Ventricle

  • Abstract C05 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C05 Figure 2

    CT scan of chest with large necrotic mass in right lung apex

  • Abstract C53 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C53 Figure 1

    Peripheral blood smear with multiply infected RBC’s with plasmodium falciparum

  • Abstract A12 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A12 Figure 1

    (A) miMCD cell extracts; (B) HRCTE cell extracts; (C) rat urine; (D) patient urine

  • Abstract A12 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A12 Figure 2
  • Abstract A12 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A12 Figure 3
  • Abstract A12 Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A12 Figure 4
  • Abstract A23 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A23 Figure 1

    tFGF23 levels with iron sucrose treatment

  • Abstract A23 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A23 Figure 2

    iFGF23 levels with iron sucrose treatment

  • Abstract C39 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract C39 Figure 1
  • Abstract B28 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B28 Figure 1
  • Abstract A02 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract A02 Figure 1
  • Abstract B31 Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B31 Figure 1
  • Abstract B31 Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B31 Figure 2
  • Abstract B31 Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Abstract B31 Figure 3

Tables

  • Figures
  • Abstract C42 Table 1
  • Abstract C42 Table 2
  • Abstract C42 Table 3
  • Abstract C16 Table 1

    Demographics, comorbidities, and clinical data according to factors of admission

    Overall (n=109) A (n=15) B (n=19) C (n=22) D (n=5) E (n=33) F (n=15)
    Age (years) 56±13 54±9 53±13 52±12 59±20 59±14 66±12
    Sex (% Male) 68 73 79 59 80 60 73
    Hispanic (%) 63 73 79 68 60 51 53
    Non-Hispanic White (%) 21 20 15.79 4.55 20 27.27 40
    DM (%) 51 53.3 57.9 40.9 25 57.6 53.3
    HTN (%) 70 80 84.2 59.1 25 72.7 66.7
    CVA (%) 14 20 10.5 9.1 0 15.2 20
    PVD (%) 9 20 15.8 4.6 0 6.1 13.1
    Current Smoker (%) 28 33.3 15.8 36.4 20 21.2 40
    SBP (mmHg) 134±27 145±32 128±28 144±26 113±10 127±23 137±19
    DBP (mmHg) 82±20 91±25 81±21 91±22 76±18 76±16 77±14
    EF (%) 31±18 26±17 33±21 27±15 30±19 36±17 37±22
    PASP (mmHg) 45±12 40±10 43±9.51 45±11 58±10 48±15 46±12
    • DM=diabetes mellitus, HTN=hypertension, CVA=cerebral vascular accident, PVD=peripheral vascular disease, SBP=systolic blood pressure, DBP=diastolic blood pressure, EF=ejection fraction, PASP=pulmonary artery systolic pressure

  • Abstract C53 Table 1
  • Abstract A23 Table 1

    Characteristics before and after iron sucrose infusion

    N=22 Pre-iron sucrose Post-iron sucrose
    Age, yrs 56±13.4 -
    Female, % 73 -
    Ferritin (ng/mL) 47 (30, 74) 252 (205, 386)
    Transferrin Saturation (%) 19±6 25±6
    Hemoglobin (g/dL) 10.5±1.0 11.0±1.2
    eGFR ml/min/1.73m2 32.8±18.4 31.9±17.8
    Phosphorus (mg/dL) 3.7±0.7 3.6±0.9
    tFGF23 (Ru/ml) 367 (164, 535) 176 (92, 566)
    iFGF23 (pg/ml) 162 (81, 473) 134 (97, 536)
  • Abstract A46 Table 1

    Clinical characteristics by outcome

    All (n=80)Failure (n=24)Success (n=56)p-value
    Diabetes, % 61.2 50.0 66.1 0.2
    Aspirin, % 56.2 33.3 66.1 0.007
    Indication for procedure, % 55.0 33.3 64.3 0.01
    Multiple stenoses, % 42.5 41.7 42.9 0.4
    Cephalic arch stenosis, % 17.5 12.5 19.6 0.4
    Pre-PTA stenosis 59.6 (17.1) 60.8 (18.9) 59.1 (16.3) 0.6
    POst-PTA stenosis 19.8 (14.2) 16.9 (12.3) 21.0 (14.8) 0.15
    Change in stenosis after PTA 39.8 (19.1) 43.9 (20.5) 38.1 (18.3) 0.13
  • Abstract B24 Table 1

    Demographics

    Age range 30–96
    Mean Age 67
    Gender Distribution Male – 21
    Female – 17
  • Abstract B24 Table 2

    Comparison of drug treatment

    Vancomycin group (n=18) Cefazolin group (n=20)
    Repeat 3 3
    Recurrent - 1
    Relapse 2 -
  • Abstract B24 Table 3

    In vs out patient

    In (n=22) Out (n=16)
    Repeat 4 2
    Recurrent 1 -
    Relapse 1 1
  • Abstract B24 Table 4

    Vancomycin treatment in vs out patient

    Vancomycin in (n=15) Vancomycin out (n=3)
    Repeat 2 1
    Recurrent - -
    Relapse 1 1
  • Abstract B24 Table 5

    Cefazolin treatment in vs out patient

    Cefazolin in (n=7) Cefazolin out (n=13)
    Repeat 2 1
    Recurrent 1 -
    Relapse - -
  • Abstract C08 Table 1
  • Abstract C08 Table 2
  • Abstract C08 Table 3
PreviousNext
Back to top
Vol 66 Issue 4 Table of Contents
Journal of Investigative Medicine: 66 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on JIM.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Midwestern Regional Meeting
(Your Name) has sent you a message from JIM
(Your Name) thought you would like to see the JIM web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Midwestern Regional Meeting
Journal of Investigative Medicine Apr 2018, 66 (4) 784-886; DOI: 10.1136/jim-2018-000745.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Midwestern Regional Meeting
Journal of Investigative Medicine Apr 2018, 66 (4) 784-886; DOI: 10.1136/jim-2018-000745.1
Download PDF

Share
Midwestern Regional Meeting
Journal of Investigative Medicine Apr 2018, 66 (4) 784-886; DOI: 10.1136/jim-2018-000745.1
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Midwestern Regional Meeting, Thursday, April 26–27, 2018, Chicago, IL, Cardiology/Cardiovascular Disease
    • Diagnosis or Treatment of a Disease Process or Clinical Syndromes
    • Endocrinology/Metabolism
    • Epidemiology/Health Outcomes/Quality Improvement/Bio-Informatics
    • Gastroenterology/Clinical Nutrition
    • Hematology and Oncology
    • Infectious Disease
    • Nephrology
    • Neurology/Neurodegeneration
    • Pathophysiology
    • Pulmonary/Critical Care
    • Rheumatology/Immunology/Allergy
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

Similar Articles

 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Subscribe
  • Thank you to our reviewers
  • American Federation for Medical Research

AUTHORS

  • Information for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2022 American Federation for Medical Research